Group items tagged

2009 study finds that in 3502 cases of mumps, 97% of the adolescents had received the mumps vaccine (89% 2 doses and an additional 9% 1 dose).

IV vitamin C shown to be beneficial in treatment of renal cell cancer, colorectal cancer, pancreatic cancer, non-Hodgkin's lymphoma, and breast cancer without toxic side effects.  The doses provided here were high dose and these are patients that are very unhealthy.

Study looked at aromatase activity in androgen production in older men.  The study found that aromatase inhibition with arimidex increased Testosterone production.  PSA was also monitored and PSA increased in the smaller dose group versus the high dose group.

Another ill conceived conclusion by the authors.  IF you are going to study something, know everything about it.  They authors make a major statement about vitamin D, yet they seem to understand a basic understanding of vitamin dosing.  The authors stated that dosing 2,000 IU of vitamin D in those with levels < 50 provided no benefit.  That is of course correct, because 2,000 IU daily won't hold any levels stable, let alone increase levels to 70-80 where they need to be.  The authors of this study are stuck in the traditional RDC thinking here. What is interesting is that low vitamin D was associated with CVD, MS, dyslipidemia, inflammation, glucose dysmetabolism, infections, mood disorders, decline in cognition, impaired physical functioning, and all-cause mortality,  But, vitamin D supplementation is only good for bones.  The authors of this study make a mockery of medicine.

Vitamin D3 replacement was found to decrease fasting glucose, decrease insulin, increase insulin sensitivity, and decrease total cholesterol and LDL in pregnant women with gestational diabetes.  The dosing here was 50,000 IU x 2 doses taken 3 weeks apart. 

Astaxanthin at 20 mg found to reduce oxidized LDL and other oxidative stress biomarkers as assessed by Malondialdehydy, SOD, Isoprostane, and TAC.  The dose was 20 mg for 12 weeks. This higher dose was associated with minimal side effects--red stools.

low dose vitamin D plus higher dose of calcium reduced stress fractures in female military recruits.

High dose of estrogen associated with increase CRP in men.  Definitely a dose dependent response.

low dose naltrexone plus opiate therapy improves neuropathic pain

Study finds non-hormonal therapy to manage hot flashes in postmenopausal women--drug them.  The authors of this study, looked to gabapentin, also known as neurontin to treat hot flashes.  Instead of looking at the causes: hormone imbalance, stress... these authors looked to a sedating drug.  The dosing of neurontin was 900 mg.   Most can't stand at this dose.  This study points to the lunacy in the research today.  Very soon, there will be the walking dead among us.  They will be the walking doped instead of dead.

DCA as proposed therapy in cancer.

Low dose IL-2 + high dose melatonin increases 1 year survival in the treatment of solid tumors in pilot study.

Increased disease stabilization and lack of progression of solid tumor disease with low dose IL-2 and high dose melatonin.

Study finds that vitamin C inhibits pro-oxidant effects of artesunate at doses of 400 microM/L; Same with doxycycline. The problem here is that that translates to 5 mg/dL of vitamin C. Studies have shown that vitamin C's effect in cancer is attributable in part to its dose and the presence of metals.

High dose IV vitamin C effective against melanoma review finds. Low dose appears to promote melanoma.

Renal dosing of antibiotics

Pegvisomant shown to provide more GH, IGF-1 suppression compared to octreotide. The doses used were 40, 60, and 80 mg SQ. The higher dose resulted in the greatest suppression.

Very interesting study.  High fat diet in rats induced gut flora change that resulted in LPS which induced appetite through leptin resistance and reduced cholecystokinin signaling.

Case study of vitamin C IV up to 75 grams IV effective in stabilizing breast cancer with mets to liver.

High dose vitamin C found to be effective in partial regression of pancreatic cancer.